D'Argenio G, Mazzacca G
Gastrointestinal Unit, School of Medicine, Federico II University, Naples, Italy.
Adv Exp Med Biol. 1999;472:149-58. doi: 10.1007/978-1-4757-3230-6_13.
Short chain fatty acids (SCFAs) are the end products of anaerobic bacteria break down of carbohydrates in the large bowel. This process, namely fermentation, is an important function of the large bowel; SCFAs, mainly acetate, propionate and butyrate account for approximately 80% of the colonic anion concentration and are produced in nearly constant molar ratio 60:25:15. Among their various properties, SCFAs are readily absorbed by intestinal mucosa, are relatively high in caloric content, are metabolized by colonocytes and epatocytes, stimulate sodium and water absorption in the colon and are trophic to the intestinal mucosa. While the fermentative production of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in ruminants, the interest in the effects of SCFAs production on the human organism has been raising in the last ten years. SCFAs are of major importance in understanding the physiological function of dietary fibers and their possible role in intestinal neoplasia. SCFAs production and absorption are closely related to the nourishment of colonic mucosa, its production from dietary carbohydrates is a mechanism whereby considerable amounts of calories can be produced in short-bowel patients with remaining colonic function and kept on an appropriate dietary regimen. SCFAs enemas or oral probiotics are a new and promising treatment for ulcerative colitis. The effects have been attributed to the oxidation of SCFAs in the colonocytes and to the ability of butyrate to induce enzymes (i.e. transglutaminase) promoting mucosal restitution. Evidence is mounting regarding the effects of butyrate on various cell functions the significance of which needs further considerations. Up until now, attention has been related especially to cancer prophylaxis and treatment. This article briefly reviews the role of SCFAs, particularly butyrate, in intestinal mucosal growth and potential clinical applications in inflammatory and neoplastic processes of the large bowel.
短链脂肪酸(SCFAs)是大肠中厌氧细菌分解碳水化合物的终产物。这个过程,即发酵,是大肠的一项重要功能;SCFAs主要包括乙酸盐、丙酸盐和丁酸盐,约占结肠阴离子浓度的80%,且以近恒定的摩尔比60:25:15产生。在其各种特性中,SCFAs易于被肠黏膜吸收,热量含量相对较高,可被结肠细胞和肝细胞代谢,刺激结肠中钠和水的吸收,并且对肠黏膜有营养作用。虽然SCFAs的发酵产生被认为是反刍动物肠道消化的主要机制,但在过去十年中,人们对SCFAs产生对人体的影响的兴趣一直在增加。SCFAs在理解膳食纤维的生理功能及其在肠道肿瘤形成中的可能作用方面具有重要意义。SCFAs的产生和吸收与结肠黏膜的营养密切相关,其由膳食碳水化合物产生是一种机制,通过该机制,具有结肠功能的短肠患者可以产生大量热量,并维持适当的饮食方案。SCFAs灌肠剂或口服益生菌是治疗溃疡性结肠炎的一种新的、有前景的方法。其效果归因于结肠细胞中SCFAs的氧化以及丁酸盐诱导促进黏膜修复的酶(即转谷氨酰胺酶)的能力。关于丁酸盐对各种细胞功能的影响的证据越来越多,其意义需要进一步考虑。到目前为止,人们的注意力尤其集中在癌症预防和治疗方面。本文简要综述了SCFAs,特别是丁酸盐,在肠道黏膜生长中的作用以及在大肠炎症和肿瘤形成过程中的潜在临床应用。